Gene Patenting

Human Gene Patents Struck Down: Reactions from the Plaintiffs

By Sandra S. Park, ACLU Women's Rights Project at 4:18pm

For the last four years, I've had the honor of representing 20 amazing organizations and individuals in our challenge to human gene patents. They include: leading organizations of pathologists and geneticists; scientists, physicians, and genetic counselors who work every day to improve our understanding of the connection between genes, disease, and treatment and the care they provide to patients; breast cancer and women's health groups, who spoke out against the effects of these patents on patients; and women who have family histories of breast and ovarian cancer, or who have already been diagnosed with cancer, and faced obstacles to their medical care because of these patents.

VICTORY! Supreme Court Decides: Our Genes Belong to Us, Not Companies

By Sandra S. Park, ACLU Women's Rights Project at 11:35am

Should companies be able to patent human genes? Today, the Supreme Court answered that profound question with a resounding NO.

Seems like common sense, right? But over the last 30 years, the U.S. Patent Office has issued patents on thousands of human genes, including genes associated with colon cancer, Alzheimer's disease, muscular dystrophy, and many other devastating diseases. The status quo meant that companies controlling gene patents had the right to stop all other scientists from examining, studying, testing, and researching our genes.

Barbara Brenner, 1951-2013

By Bennett Stein, ACLU Speech, Privacy and Technology Project at 11:00am

The ACLU mourns the loss of a great leader, tenacious activist, and close friend of the organization. Barbara Brenner, the longtime director of Breast Cancer Action ("BCA"), was a frequent and trusted ACLU collaborator – as an employee at the ACLU of Southern California's women's rights project, as a law intern at the ACLU of Northern California, as an affiliate and national board member, as a cooperating attorney, and, most recently, as a client.

Are Genes Patentable? An Insider's Review of the ACLU's Supreme Court Argument on Gene Patenting

By Lenora M. Lapidus, Women's Rights Project at 2:01pm

In honor of DNA Day, celebrated on April 25, the ACLU gives you an insider's take on our Supreme Court Argument on gene patenting.

Are human genes patentable? That is the question at issue in AMP v. Myriad Genetics, which the ACLU argued before the Supreme Court on Monday, April 15.

Today's the Day: Challenging Human Gene Patents Before the Supreme Court

By Sandra Park, ACLU at 10:16am

Today, we're headed to the U.S. Supreme Court for oral argument in our challenge to human gene patents...

Filmmaker Joanna Rudnick on Life with the “Breast Cancer Gene” and Human Gene Patenting

By Joanna Rudnick, Activist, Filmmaker at 1:19pm

In the Family (POV 2008) tells the first-person story of director Joanna Rudnick as she tries to decide on a course of action after testing positive for the BRCA1 mutation, the "breast cancer gene." To raise public awareness of the issues being presented in the April 15th Supreme Court hearing in our case challenging gene patents, Rudnick, POV, and Kartemquin Films will re-release the film online for free streaming. The film features Rudnick's probing interview with Myriad Genetics' founder about its patents on the genes. Today, Rudnick gives POV an update on her health and personal life, and addresses the upcoming Supreme Court case regarding human gene patenting. An excerpt of the update appears below – to read Rudnick's thoughts in full, and to watch In the Family, go to: http://to.pbs.org/ZjQjcW

Voices on Human Gene Patents: It's Time to Free Our Genes

By Christopher E. Mason, Assistant Professor of Computational Genomics, Weill Cornell Medical College, Affiliate Fellow, Information Society Project of Yale Law School & Jeffrey Rosenfeld, Assistant Professor of Medicine, New Jersey Medical School at 12:29pm

Even though they’ve been in our families since the dawn of man, our genes do not belong to us. They’ve been claimed by companies that hold patents on the DNA from our cells. Over the past 20 years, at least 41 percent of our genes have become the intellectual property of corporations. These patent claims contradict an intuitive sense that our DNA is no less ours than our lungs or kidneys. More importantly, these patents, covering thousands of human genes, restrict our doctors’ ability to look at our DNA and plan ahead for our medical treatment.

Voices on Human Gene Patents: Gene Discovery, Patents, and the Community

By Sue Friedman, DVM, Founder, Executive Director, FORCE: Facing Our Risk of Cancer Empowered at 11:32am

Recently a dear friend sent me a link to an article in the February 1996 issue of Nature Medicine. The article...

Remembering the Real Purpose of Patents

By James Evans, Bryson Distinguished Professor of Genetics and Medicine, University of North Carolina - Chapel Hill School of Medicine at 10:44am

James Evans, MD, PhD is the Bryson Distinguished Professor of Genetics and Medicine at the University of North Carolina Chapel Hill School of Medicine. He was a member of the advisory committee to the U.S. Secretary of Health and Human Services on Genetics, Health and Society and spearheaded that committee's task force investigating gene patenting and its effect on patient care. He also filed an amicus brief in the ACLU's challenge to gene patents.

Statistics image